Shares of Teladoc Health, Inc. (NYSE: TDOC) have been assigned a consensus recommendation of “Hold” by the seventeen brokerages monitoring the company, according to Marketbeat Ratings. Of these analysts, one has issued a sell rating, eleven have given a hold rating, and five have offered a buy rating. The average twelve-month price target for the stock stands at $9.61.
Several research firms have provided insights on Teladoc Health, with BMO Capital Markets initiating coverage on November 13, 2023, and assigning a “market perform” rating with a price objective of $8.00. Similarly, Weiss Ratings reiterated a “sell (d-)” rating on October 8, 2023, while Evercore ISI adjusted their price target from $9.00 to $8.00 on October 30, 2023, maintaining an “in-line” rating. In contrast, Citigroup raised their price objective from $9.50 to $10.50 on October 21, 2023, categorizing the stock as “neutral.” Notably, Zacks Research downgraded the stock from a “strong-buy” to a “hold” rating on November 10, 2023.
Current Market Performance and Financial Indicators
On Friday, Teladoc Health opened at $6.94. The company reports a quick ratio of 2.60, a current ratio of 2.70, and a debt-to-equity ratio of 0.71. Over the past year, the stock has seen a low of $6.35 and a high of $15.21. Its 50-day moving average is $8.12, while the 200-day moving average is $7.75. The market capitalization of Teladoc Health is approximately $1.23 billion, with a price-to-earnings ratio of -5.42 and a beta of 1.92.
The company’s latest earnings report, released on October 29, 2023, indicated a loss of ($0.21) earnings per share, exceeding analysts’ consensus estimate of ($0.26) by $0.05. Revenue for the quarter reached $626.44 million, slightly surpassing analyst expectations of $625.66 million. In comparison to the same quarter last year, revenue declined by 2.2%. For Q4 2025, Teladoc Health has projected a guidance range of ($0.250) to ($0.100) earnings per share. Analysts forecast that the company will report an average of ($1.16) earnings per share for the current year.
About Teladoc Health
Teladoc Health, Inc. provides virtual healthcare services globally. The company operates through two primary segments: Teladoc Health Integrated Care and BetterHelp. The Integrated Care segment includes virtual medical services such as general medical, expert medical, specialty medical, chronic condition management, and mental health services, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Investors and stakeholders can stay updated on the latest news and analysis regarding Teladoc Health through various platforms, including MarketBeat’s daily email newsletter.
